Search

everythinglearnresearchcommunity

for

Search:↓

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

IL-1 alpha stops hair follicle growth and hair production.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Some drugs may help treat both COVID-19 and radiation injury.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

New treatments for seborrheic dermatitis show promise for difficult cases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.